Petitclerc D, Lauzon K, Cochu A, Ster C, Diarra M S, Lacasse P
Crea Biopharma Inc., Sherbrooke, Quebec, Canada J1E 4K8.
J Dairy Sci. 2007 Jun;90(6):2778-87. doi: 10.3168/jds.2006-598.
The efficacy of intramammary (IM) treatments containing penicillin G (PG) alone or a combination of PG and bovine lactoferrin (bLF) was evaluated using a model of experimentally induced chronic bovine mastitis caused by a clinical isolate of Staphylococcus aureus highly resistant to beta-lactam antibiotics. First, we confirmed that this strain could cause mastitis and infection could not be cured with PG alone. In a second trial, chronic mastitis was induced in 19 late-lactating cows by injecting a low dose of Staph. aureus through the teat canal of all quarters. After 15 d, cows with stable infections in their 4 quarters had their mammary quarters randomly assigned, within cow, to 1 of 4 IM treatments as follows: 1) citrate buffer, 2) 100,000 IU of PG, (3) 1 g of bLF, or 4) 1 g of bLF + 100,000 IU of PG. Treatments were repeated twice a day for 5 d. A third trial was undertaken to investigate the effect of an extended therapy on chronic mastitis acquired in a previous lactation. One month before dry-off, 20 gravid cows regrouped by dates of calving were infected in their 4 quarters. Once infections were established, cows were dried off abruptly. After calving, aseptic milk samples were collected separately from all quarters for 4 wk to monitor infection. Mammary quarters from enrolled cows were then randomly assigned, within cow, to 1 of 2 treatments as follows: 1) 100,000 IU of PG or 2) 250 mg of bLF + 100,000 IU of PG. Treatments were administered IM twice a day for 7 d. For all trials, milk samples were taken to monitor bacterial concentration and somatic cell count. Bacteriological cure rate was determined using milk samples taken 3 and 4 wk after initiation of treatments. For the second trial, cure rate was null for control quarters, 11.1% for bLF, 9.1% for PG, and 45.5% for the bLF + PG combination. For cows infected in their previous lactation, cure rate was higher for the bLF + PG combination (33.3%) compared with PG alone (12.5%). In conclusion, bLF added to PG is an effective combination (i.e., 3- to 5-times higher cure rate) for the treatment of stable Staph. aureu infections highly resistant to beta-lactam antibiotics.
使用由对β-内酰胺抗生素高度耐药的金黄色葡萄球菌临床分离株引起的实验性慢性牛乳腺炎模型,评估了单独含有青霉素G(PG)或PG与牛乳铁蛋白(bLF)组合的乳房内(IM)治疗的疗效。首先,我们证实该菌株可引起乳腺炎,单独使用PG无法治愈感染。在第二项试验中,通过向19头晚孕奶牛的所有乳腺乳管注射低剂量的金黄色葡萄球菌,诱导慢性乳腺炎。15天后,4个乳腺区感染稳定的奶牛,其乳腺区在奶牛内随机分配到以下4种IM治疗之一:1)柠檬酸盐缓冲液,2)100,000 IU的PG,3)1 g的bLF,或4)1 g的bLF + 100,000 IU的PG。治疗每天重复2次,持续5天。进行了第三项试验,以研究延长治疗对前一胎获得的慢性乳腺炎的影响。干奶前1个月,将20头按产犊日期重新分组的妊娠奶牛的4个乳腺区进行感染。一旦感染确立,奶牛立即干奶。产犊后,从所有乳腺区分别采集无菌奶样4周,以监测感染情况。然后将入选奶牛的乳腺区在奶牛内随机分配到以下2种治疗之一:1)100,000 IU的PG或2)250 mg的bLF + 100,000 IU的PG。治疗通过IM每天给药2次,持续7天。对于所有试验,采集奶样以监测细菌浓度和体细胞计数。使用治疗开始后3周和4周采集的奶样确定细菌治愈率。对于第二项试验,对照乳腺区的治愈率为零,bLF为11.1%,PG为9.1%,bLF + PG组合为45.5%。对于前一胎感染的奶牛,bLF + PG组合的治愈率(33.3%)高于单独使用PG(12.5%)。总之,添加到PG中的bLF是治疗对β-内酰胺抗生素高度耐药的稳定金黄色葡萄球菌感染的有效组合(即治愈率高3至5倍)。